Cargando…

The Evolution of Methotrexate as a Treatment for Ectopic Pregnancy and Gestational Trophoblastic Neoplasia: A Review

Methotrexate was developed in 1949 as a synthetic folic acid analogue to compete with folic acid and thus interfere with cell replication. While initially developed as a potential treatment for acute lymphoblastic leukaemia, a serendipitous observation led to methotrexate's use to effect the dr...

Descripción completa

Detalles Bibliográficos
Autores principales: Skubisz, Monika M., Tong, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scholarly Research Network 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3302016/
https://www.ncbi.nlm.nih.gov/pubmed/22462004
http://dx.doi.org/10.5402/2012/637094